Yousefi, A., Saraee, E., & Ghalehtaki, R. (2026). Defying the Odds in Recurrent Glioblastoma: Complete Response following Salvage Therapy with Bevacizumab and Irinotecan – A Case Report. Case Reports in Oncology, 19(1), 238. https://doi.org/10.1159/000549567
Chicago Style (17th ed.) CitationYousefi, Ava, Ehsan Saraee, and Reza Ghalehtaki. "Defying the Odds in Recurrent Glioblastoma: Complete Response Following Salvage Therapy with Bevacizumab and Irinotecan – A Case Report." Case Reports in Oncology 19, no. 1 (2026): 238. https://doi.org/10.1159/000549567.
MLA (9th ed.) CitationYousefi, Ava, et al. "Defying the Odds in Recurrent Glioblastoma: Complete Response Following Salvage Therapy with Bevacizumab and Irinotecan – A Case Report." Case Reports in Oncology, vol. 19, no. 1, 2026, p. 238, https://doi.org/10.1159/000549567.